Literature DB >> 28235708

Prevalence of feline calicivirus in cats with odontoclastic resorptive lesions and chronic gingivostomatitis.

Sheeba Thomas1, David F Lappin2, Julie Spears1, David Bennett2, Christopher Nile3, Marcello P Riggio4.   

Abstract

Feline odontoclastic resorptive lesion (FORL) and feline chronic gingivostomatitis (FCGS) are two of the most common diseases of the feline oral cavity. While evidence is emerging that FCGS is caused by gingival inflammation initiated and perpetuated by the oral microbiota, little is known in this regard for FORL. Feline calicivirus (FCV) has been associated with the presence of FCGS and is thought to play a role in the initiation of this disease. In this study, the incidence of FCV was investigated in cats with FORL and FCGS, and compared to unaffected controls. FCV was detected by viral culture. The incidence of FCV was as follows: 6 (24.0%) of 24 control cats, 9 (22.5%) of 40 cats with FORL and 15 (60.0%) of 25 cats with FCGS were positive for FCV. There was a significant difference in FCV incidence between all the groups (p=0.003) but none between the control group and the FORL group. However, significant differences were observed in the incidence of FCV between control and FCGS (p=0.010) and between FORL and FCGS (p=0.006). It is concluded that although FCV may be associated with FCGS, it appears unlikely to play a role in FORL.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Feline; Feline calicivirus; Gingivostomatitis; Inflammation; Resorptive lesion

Mesh:

Year:  2017        PMID: 28235708     DOI: 10.1016/j.rvsc.2017.02.004

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  7 in total

1.  Secretory Profile of Adipose-Tissue-Derived Mesenchymal Stem Cells from Cats with Calicivirus-Positive Severe Chronic Gingivostomatitis.

Authors:  Antonio J Villatoro; María Del Carmen Martín-Astorga; Cristina Alcoholado; Liliya Kazantseva; Casimiro Cárdenas; Fernando Fariñas; José Becerra; Rick Visser
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

Review 2.  Calicivirus Infection in Cats.

Authors:  Regina Hofmann-Lehmann; Margaret J Hosie; Katrin Hartmann; Herman Egberink; Uwe Truyen; Séverine Tasker; Sándor Belák; Corine Boucraut-Baralon; Tadeusz Frymus; Albert Lloret; Fulvio Marsilio; Maria Grazia Pennisi; Diane D Addie; Hans Lutz; Etienne Thiry; Alan D Radford; Karin Möstl
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

3.  The subgingival microbial community of feline periodontitis and gingivostomatitis: characterization and comparison between diseased and healthy cats.

Authors:  Marjory Xavier Rodrigues; Rodrigo Carvalho Bicalho; Nadine Fiani; Svetlana Ferreira Lima; Santiago Peralta
Journal:  Sci Rep       Date:  2019-08-26       Impact factor: 4.379

Review 4.  An Update on Feline Chronic Gingivostomatitis.

Authors:  Da Bin Lee; Frank J M Verstraete; Boaz Arzi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2020-04-18       Impact factor: 2.093

5.  Multiple Correspondence Analysis on Amino Acid Properties within the Variable Region of the Capsid Protein Shows Differences between Classical and Virulent Systemic Feline Calicivirus Strains.

Authors:  Sylvie Brunet; Cécile Sigoillot-Claude; Daniel Pialot; Hervé Poulet
Journal:  Viruses       Date:  2019-11-23       Impact factor: 5.048

6.  Natural cases of polyarthritis associated with feline calicivirus infection in cats.

Authors:  Andrea Balboni; Ranieri Verin; Isotta Buldrini; Silvia Zamagni; Maria Morini; Alessia Terrusi; Laura Gallina; Lorenza Urbani; Francesco Dondi; Mara Battilani
Journal:  Vet Res Commun       Date:  2022-05-05       Impact factor: 2.816

7.  A pilot study to evaluate the serum Alpha-1 acid glycoprotein response in cats suffering from feline chronic gingivostomatitis.

Authors:  Lisa A Mestrinho; Rita Rosa; Patrícia Ramalho; Vasco Branco; Leonor Iglésias; Hugo Pissarra; Ana Duarte; Maria Niza
Journal:  BMC Vet Res       Date:  2020-10-15       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.